Mineralys Therapeutics, Inc.

MLYS Nasdaq SEC CIK 1933414
Follow Mineralys Therapeutics Weekly email: filings, results, news

News

3 stories filed under Mineralys Therapeutics, grouped into ongoing threads

More coverage